MeiraGTx Holdings (MGTX) Common Equity (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Common Equity of -$5.8 million for Q4 2025, up 85.72% on a QoQ basis from -$40.6 million in Q3 2025, and down 108.54% year-over-year from $67.8 million in Q4 2024.
MeiraGTx Holdings (MGTX) Common Equity (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Common Equity history runs 9 years deep, the most recent figure standing at -$5.8 million for Q4 2025.
- Quarterly Common Equity fell 108.54% year-over-year to -$5.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.8 million (down 108.54% YoY) and the FY2025 annual result came in at -$5.8 million, down 108.54% from the prior year.
- Common Equity was -$5.8 million for Q4 2025 at MeiraGTx Holdings, up from -$40.6 million in the prior quarter.
- Across five years, Common Equity topped out at $220.8 million in Q1 2021 and bottomed at -$40.6 million in Q3 2025.
- A 5-year average of $107.1 million and a median of $119.7 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2024 — Common Equity surged 34.93% — and 2025, when it sank 142.36%.
- MeiraGTx Holdings' Common Equity stood at $185.4 million in 2021, then tumbled by 36.5% to $117.7 million in 2022, then advanced by 17.36% to $138.2 million in 2023, then sank by 50.91% to $67.8 million in 2024, then tumbled by 108.54% to -$5.8 million in 2025.
- Business Quant data shows MGTX's Common Equity at -$5.8 million in Q4 2025, -$40.6 million in Q3 2025, and $3.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | -5.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.79 Mn |
| Sep 30, 2025 | -40.56 Mn |
| Jun 30, 2025 | 2.96 Mn |
| Mar 31, 2025 | 33.10 Mn |
| Dec 31, 2024 | 67.83 Mn |
| Sep 30, 2024 | 95.74 Mn |
| Jun 30, 2024 | 80.04 Mn |
| Mar 31, 2024 | 121.73 Mn |
| Dec 31, 2023 | 138.18 Mn |
| Sep 30, 2023 | 91.89 Mn |
| Jun 30, 2023 | 123.53 Mn |
| Mar 31, 2023 | 90.22 Mn |
| Dec 31, 2022 | 117.74 Mn |
| Sep 30, 2022 | 122.67 Mn |
| Jun 30, 2022 | 141.97 Mn |
| Mar 31, 2022 | 161.29 Mn |
| Dec 31, 2021 | 185.40 Mn |
| Sep 30, 2021 | 187.84 Mn |
| Jun 30, 2021 | 205.72 Mn |
| Mar 31, 2021 | 220.79 Mn |